Shares in Irish clinical trials firm Icon remain 28pc lower than where they were trading just a week before the group warned in February that it was engaged in an “ongoing internal investigation” into certain accounting practices and controls.
Simon Harris’s idea for a new state-backed savings and investment account (SIA) scheme is taking shape. Details are due to be included in October’s budget.
The firm behind Coole Swan has secured agreements with loan note holders to convert over €3m of debt into shares as the Irish cream liqueur brand aims to turn a profit next year.